GlobeNewswire by notified

Sanoma Corporation - Managers' Transactions

Share

Sanoma Corporation, Managers’ Transactions, 21 February 2024 at 9:15 EET

Sanoma Corporation - Managers' Transactions

___________________________________________
Person subject to the notification requirement
Name: Holding Manutas Oy
Position: Closely associated person
(X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer
Name: Anna Herlin
Position: Member of the Board
Issuer: Sanoma Oyj
LEI: 743700XJC24THUPK0S03
Notification type: INITIAL NOTIFICATION
Reference number: 52987/5/6
____________________________________________
Transaction date: 2024-02-20
Venue: AQEU
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 350 Unit price: 6.86 EUR
(2): Volume: 3 Unit price: 6.87 EUR
(3): Volume: 64 Unit price: 6.89 EUR
(4): Volume: 88 Unit price: 6.93 EUR
(5): Volume: 1 Unit price: 6.94 EUR
(6): Volume: 350 Unit price: 6.99 EUR

Aggregated transactions (6):
Volume: 856 Volume weighted average price: 6.92272 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: BEUP
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 160 Unit price: 6.855 EUR
(2): Volume: 320 Unit price: 6.855 EUR
(3): Volume: 160 Unit price: 6.855 EUR
(4): Volume: 477 Unit price: 6.94 EUR

Aggregated transactions (4):
Volume: 1117 Volume weighted average price: 6.8913 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: CEUD
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 525 Unit price: 6.91 EUR

Aggregated transactions (1):
Volume: 525 Volume weighted average price: 6.91 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: CEUX
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 266 Unit price: 6.86 EUR
(2): Volume: 64 Unit price: 6.89 EUR
(3): Volume: 36 Unit price: 6.89 EUR
(4): Volume: 186 Unit price: 6.93 EUR
(5): Volume: 1 Unit price: 6.96 EUR
(6): Volume: 129 Unit price: 6.95388 EUR
(7): Volume: 1 Unit price: 6.98 EUR
(8): Volume: 110 Unit price: 6.99 EUR

Aggregated transactions (8):
Volume: 793 Volume weighted average price: 6.91378 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: DHEL
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 1577 Unit price: 6.88 EUR
(2): Volume: 297 Unit price: 6.865 EUR
(3): Volume: 4840 Unit price: 6.87 EUR
(4): Volume: 262 Unit price: 6.875 EUR

Aggregated transactions (4):
Volume: 6976 Volume weighted average price: 6.87224 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: EBLX
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 68 Unit price: 6.86 EUR
(2): Volume: 155 Unit price: 6.875 EUR
(3): Volume: 9 Unit price: 6.88 EUR
(4): Volume: 43 Unit price: 6.88 EUR

Aggregated transactions (4):
Volume: 275 Volume weighted average price: 6.87224 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: EUCC
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 145 Unit price: 6.88 EUR
(2): Volume: 144 Unit price: 6.85 EUR

Aggregated transactions (2):
Volume: 289 Volume weighted average price: 6.86505 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: SGMU
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 202 Unit price: 6.85 EUR

Aggregated transactions (1):
Volume: 202 Volume weighted average price: 6.85 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: TQEX
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 55 Unit price: 6.98 EUR
(2): Volume: 110 Unit price: 6.99 EUR
(3): Volume: 55 Unit price: 7 EUR

Aggregated transactions (3):
Volume: 220 Volume weighted average price: 6.99 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 897 Unit price: 6.84 EUR
(2): Volume: 750 Unit price: 6.85 EUR
(3): Volume: 854 Unit price: 6.86 EUR
(4): Volume: 119 Unit price: 6.87 EUR
(5): Volume: 526 Unit price: 6.86 EUR
(6): Volume: 197 Unit price: 6.89 EUR
(7): Volume: 1250 Unit price: 6.88 EUR
(8): Volume: 1459 Unit price: 6.87 EUR
(9): Volume: 587 Unit price: 6.89 EUR
(10): Volume: 1644 Unit price: 6.93 EUR
(11): Volume: 855 Unit price: 6.94 EUR
(12): Volume: 356 Unit price: 6.94 EUR
(13): Volume: 394 Unit price: 6.96 EUR
(14): Volume: 3 Unit price: 6.95 EUR
(15): Volume: 2395 Unit price: 6.95977 EUR
(16): Volume: 1250 Unit price: 6.96 EUR
(17): Volume: 144 Unit price: 6.96 EUR
(18): Volume: 559 Unit price: 6.98 EUR
(19): Volume: 1428 Unit price: 6.99 EUR
(20): Volume: 271 Unit price: 7 EUR
(21): Volume: 113 Unit price: 6.99 EUR
(22): Volume: 2390 Unit price: 6.98 EUR

Aggregated transactions (22):
Volume: 18441 Volume weighted average price: 6.92838 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: POSIT (XPOS)
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 4104 Unit price: 6.87 EUR
(2): Volume: 4296 Unit price: 6.87 EUR
(3): Volume: 5704 Unit price: 6.87 EUR
(4): Volume: 3872 Unit price: 6.87 EUR
(5): Volume: 2736 Unit price: 6.87 EUR
(6): Volume: 2024 Unit price: 6.87 EUR
(7): Volume: 1368 Unit price: 6.87 EUR
(8): Volume: 10000 Unit price: 6.87 EUR
(9): Volume: 5441 Unit price: 6.87 EUR
(10): Volume: 1026 Unit price: 6.87 EUR
(11): Volume: 364 Unit price: 6.87 EUR
(12): Volume: 365 Unit price: 6.86 EUR
(13): Volume: 160 Unit price: 6.87 EUR
(14): Volume: 85 Unit price: 6.86 EUR
(15): Volume: 160 Unit price: 6.86 EUR
(16): Volume: 814 Unit price: 6.875 EUR
(17): Volume: 10000 Unit price: 6.875 EUR
(18): Volume: 8020 Unit price: 6.875 EUR
(19): Volume: 1026 Unit price: 6.875 EUR
(20): Volume: 954 Unit price: 6.875 EUR
(21): Volume: 1046 Unit price: 6.875 EUR
(22): Volume: 86 Unit price: 6.88 EUR
(23): Volume: 160 Unit price: 6.885 EUR
(24): Volume: 167 Unit price: 6.89 EUR
(25): Volume: 362 Unit price: 6.915 EUR
(26): Volume: 160 Unit price: 6.99 EUR

Aggregated transactions (26):
Volume: 64500 Volume weighted average price: 6.87225 EUR
____________________________________________
Transaction date: 2024-02-20
Venue: XTXE
Instrument type: SHARE
ISIN: FI0009007694
Nature of transaction: ACQUISITION

Transaction details
(1): Volume: 5431 Unit price: 6.88 EUR
(2): Volume: 375 Unit price: 6.87 EUR

Aggregated transactions (2):
Volume: 5806 Volume weighted average price: 6.87935 EUR


Sanoma 
Sanoma is an innovative and agile learning and media company impacting the lives of millions every day. Our Sustainability Strategy is designed to maximise our positive ‘brainprint’ on society and to minimise our environmental footprint. We are committed to the UN Sustainable Development Goals and signatory to the UN Global Compact.

Our learning products and services enable teachers to develop the talents of every child to reach their full potential. We offer printed and digital learning content as well as digital learning and teaching platforms for primary, secondary and vocational education, and want to grow our business.

Our Finnish media provide independent journalism and engaging entertainment also for generations to come. Our unique cross-media position offers the widest reach and tailored marketing solutions for our business partners.

Today, we operate in twelve European countries and employ more than 5,000 professionals. In 2023, our net sales amounted to approx. 1.4bn€ and our operational EBIT margin excl. PPA was 12.6%. Sanoma shares are listed on Nasdaq Helsinki. More information is available at sanoma.com.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Havila Shipping ASA: Årsrapport 202319.4.2024 17:06:25 CEST | Pressemelding

Styret i Havila Shipping ASA har i dag godkjent regnskap og årsrapport for 2023 for konsern og morselskap. Resultatregnskap og balanser er i samsvar med foreløpig regnskap offentliggjort 27. februar 2024. Kontakter: Administrerende direktør Njål Sævik, +47 909 35 722 Finansdirektør Arne Johan Dale, +47 909 87 706 Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12 Vedlegg HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Havila Shipping ASA : Annual Report 202319.4.2024 17:06:25 CEST | Press release

Today, the Board of Directors of Havila Shipping ASA has approved the financial statements for 2023 for both the Group and the parent company. The accounts are in line with preliminary accounts released on 27 February 2024. Contacts: Chief Executive Officer Njål Sævik, +47 909 35 722 Chief Financial Officer Arne Johan Dale, +47 909 87 706 This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments HAVI-20235967007LIEEXZXFJ8876-2023-12-31-no

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons19.4.2024 17:05:00 CEST | Press release

Company announcement – No. 23 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, has received information on transactions in Zealand's shares or related securities conducted by persons discharging managerial responsibilities and/or their closely associated persons and hereby publishes the information on such transactions. Please see the attached file(s). # # # About Zealand Pharma A/S Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 202419.4.2024 17:00:00 CEST | Press release

Company announcement – No. 22 / 2024 Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024 Copenhagen, Denmark, April 19, 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces the implementation of long-term incentive programs (the “LTIP”) for Zealand's Board of Directors, Corporate Management and employees in accordance with Zealand's remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on March 20, 2024 (“Remuneration Policy”). Long-term incentive program Zealand has made the following awards in its long-term incentive plan. It has awarded: 20,497 restricted stock units ("RSUs") to Zealand's Board of Directors 52,777 performance stock units ("PSUs") and 52,777 RSUs have been awarded to Zealand’s Corporat

Dr. Sam Barrell CBE appointed as CEO of LifeArc19.4.2024 17:00:00 CEST | Press release

PRESS RELEASE FOR IMMEDIATE PUBLICATION 19 April 2024 Dr. Sam Barrell CBE appointed as CEO of LifeArc LifeArc is pleased to announce the appointment of Dr. Sam Barrell, CBE, as Chief Executive Officer. Sam’s appointment follows an extensive international recruitment process. Sam will join LifeArc from the Francis Crick Institute where she is currently Deputy CEO with responsibility for strategic management and operational leadership, as well as deputising for the Director, Sir Paul Nurse. She joined the Crick in 2017 as Chief Operating Officer. Sam brings over 25 years of experience in the life science and healthcare sectors, and a wealth of knowledge of the activities in commercial, digital and health tech spaces which are critical to LifeArc’s strategy. She studied medicine, training as an anaesthetist and serving in General Practice for many years, and has held a number of senior leadership positions in the NHS, most recently as CEO of Taunton and Somerset NHS Foundation Trust. She

HiddenA line styled icon from Orion Icon Library.Eye